newsfilter
← Latest News
GlobeNewswire·

Chinook Therapeutics Enters into Agreement to be Acquired by Novartis AG

Novartis to acquire Chinook for $40 per share in cash, with potential to receive up to an additional $4 per share in cash through contingent value rights, for a total equity value of up to approximately $3.5